Direct compression formulation of DPPIV inhibitors and glitazones, and process

Details for Australian Patent Application No. 2011202573 (hide)

Owner Novartis AG

Inventors Patel, Arun P.; Kowalski, James; Lakshman, Jay Parthiban

Agent Davies Collison Cave

Pub. Number AU-A-2011202573

Parent 2010212516

Filing date 1 June 2011

Wipo publication date 23 June 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 June 2011 Complete Application Filed

23 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202573

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202574-Use of a DPP-IV inhibitor to reduce hypoglycemic events

2011202572-Optical method of determining a physical attribute of a moving object